 | • レポートコード：MRC2-11QY03494 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は気管支拡張薬のグローバル市場について調査・分析したレポートです。種類別（抗コリン作用性気管支拡張薬、アドレナリン作動性気管支拡張薬、気管支拡張薬配合剤、メチルキサンチン）市場規模、用途別（喘息、COPD、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別気管支拡張薬の競争状況、市場シェア ・世界の気管支拡張薬市場：種類別市場規模 2015年-2020年（抗コリン作用性気管支拡張薬、アドレナリン作動性気管支拡張薬、気管支拡張薬配合剤、メチルキサンチン） ・世界の気管支拡張薬市場：種類別市場規模予測 2021年-2026年（抗コリン作用性気管支拡張薬、アドレナリン作動性気管支拡張薬、気管支拡張薬配合剤、メチルキサンチン） ・世界の気管支拡張薬市場：用途別市場規模 2015年-2020年（喘息、COPD、その他） ・世界の気管支拡張薬市場：用途別市場規模予測 2021年-2026年（喘息、COPD、その他） ・北米の気管支拡張薬市場分析：米国、カナダ ・ヨーロッパの気管支拡張薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの気管支拡張薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の気管支拡張薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの気管支拡張薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca、Boehringer Ingelheim、GlaxoSmithKline、F. Hoffmann-La Roche ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or requires prescription. Basically there are available in three forms injectable, oral and inhaled. In oral forms they come in variety such as liquids, tablets and capsules, these oral forms are delivered in higher doses which is directly absorbed into the bloodstream and so they have relatively more side effects. Whereas inhaled once are directly deposited in the lungs causing less side effects. Bronchodilators are of basically-acting or long-acting beta2-agonists and anticholinergic agents or theophylline. They function so as to control asthma and COPD. Short acting bronchodilators function for fast relief of asthma symptoms and long acting bronchodilators function for control symptoms of asthma.
Increase in prevalence of pulmonary disorders, smoking, and junk food fuel the bronchodilators market growth. In addition, rise in disposable income, geriatric population, and increase in awareness of healthcare among population are anticipated to boost the market growth. However, side effects associated with bronchodilators and government regulations related to the safety & efficacy of the bronchodilators hinder the market. Ongoing R&D activities related to bronchodilators are anticipated to present new opportunities for the market.
Market Analysis and Insights: Global Bronchodilators Market
The global Bronchodilators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bronchodilators Scope and Market Size
Bronchodilators market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bronchodilators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bronchodilators market is segmented into
Anticholinergic Bronchodilators
Adrenergic Bronchodilators
Bronchodilator Combinations
Methylxanthines
Segment by Application, the Bronchodilators market is segmented into
Asthma
COPD
Others
Regional and Country-level Analysis
The Bronchodilators market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bronchodilators market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bronchodilators Market Share Analysis
Bronchodilators market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bronchodilators business, the date to enter into the Bronchodilators market, Bronchodilators product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline
F. Hoffmann-La Roche
…
1 Study Coverage
1.1 Bronchodilators Product Introduction
1.2 Market Segments
1.3 Key Bronchodilators Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bronchodilators Market Size Growth Rate by Type
1.4.2 Anticholinergic Bronchodilators
1.4.3 Adrenergic Bronchodilators
1.4.4 Bronchodilator Combinations
1.4.5 Methylxanthines
1.5 Market by Application
1.5.1 Global Bronchodilators Market Size Growth Rate by Application
1.5.2 Asthma
1.5.3 COPD
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bronchodilators Market Size, Estimates and Forecasts
2.1.1 Global Bronchodilators Revenue 2015-2026
2.1.2 Global Bronchodilators Sales 2015-2026
2.2 Global Bronchodilators, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bronchodilators Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bronchodilators Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bronchodilators Competitor Landscape by Players
3.1 Bronchodilators Sales by Manufacturers
3.1.1 Bronchodilators Sales by Manufacturers (2015-2020)
3.1.2 Bronchodilators Sales Market Share by Manufacturers (2015-2020)
3.2 Bronchodilators Revenue by Manufacturers
3.2.1 Bronchodilators Revenue by Manufacturers (2015-2020)
3.2.2 Bronchodilators Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bronchodilators Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bronchodilators Revenue in 2019
3.2.5 Global Bronchodilators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bronchodilators Price by Manufacturers
3.4 Bronchodilators Manufacturing Base Distribution, Product Types
3.4.1 Bronchodilators Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bronchodilators Product Type
3.4.3 Date of International Manufacturers Enter into Bronchodilators Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bronchodilators Market Size by Type (2015-2020)
4.1.1 Global Bronchodilators Sales by Type (2015-2020)
4.1.2 Global Bronchodilators Revenue by Type (2015-2020)
4.1.3 Bronchodilators Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bronchodilators Market Size Forecast by Type (2021-2026)
4.2.1 Global Bronchodilators Sales Forecast by Type (2021-2026)
4.2.2 Global Bronchodilators Revenue Forecast by Type (2021-2026)
4.2.3 Bronchodilators Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bronchodilators Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bronchodilators Market Size by Application (2015-2020)
5.1.1 Global Bronchodilators Sales by Application (2015-2020)
5.1.2 Global Bronchodilators Revenue by Application (2015-2020)
5.1.3 Bronchodilators Price by Application (2015-2020)
5.2 Bronchodilators Market Size Forecast by Application (2021-2026)
5.2.1 Global Bronchodilators Sales Forecast by Application (2021-2026)
5.2.2 Global Bronchodilators Revenue Forecast by Application (2021-2026)
5.2.3 Global Bronchodilators Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bronchodilators by Country
6.1.1 North America Bronchodilators Sales by Country
6.1.2 North America Bronchodilators Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bronchodilators Market Facts & Figures by Type
6.3 North America Bronchodilators Market Facts & Figures by Application
7 Europe
7.1 Europe Bronchodilators by Country
7.1.1 Europe Bronchodilators Sales by Country
7.1.2 Europe Bronchodilators Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bronchodilators Market Facts & Figures by Type
7.3 Europe Bronchodilators Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bronchodilators by Region
8.1.1 Asia Pacific Bronchodilators Sales by Region
8.1.2 Asia Pacific Bronchodilators Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bronchodilators Market Facts & Figures by Type
8.3 Asia Pacific Bronchodilators Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bronchodilators by Country
9.1.1 Latin America Bronchodilators Sales by Country
9.1.2 Latin America Bronchodilators Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bronchodilators Market Facts & Figures by Type
9.3 Central & South America Bronchodilators Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bronchodilators by Country
10.1.1 Middle East and Africa Bronchodilators Sales by Country
10.1.2 Middle East and Africa Bronchodilators Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bronchodilators Market Facts & Figures by Type
10.3 Middle East and Africa Bronchodilators Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Bronchodilators Products Offered
11.1.5 AstraZeneca Related Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Description and Business Overview
11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Boehringer Ingelheim Bronchodilators Products Offered
11.2.5 Boehringer Ingelheim Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Bronchodilators Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Description and Business Overview
11.4.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Bronchodilators Products Offered
11.4.5 F. Hoffmann-La Roche Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Bronchodilators Products Offered
11.1.5 AstraZeneca Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bronchodilators Market Estimates and Projections by Region
12.1.1 Global Bronchodilators Sales Forecast by Regions 2021-2026
12.1.2 Global Bronchodilators Revenue Forecast by Regions 2021-2026
12.2 North America Bronchodilators Market Size Forecast (2021-2026)
12.2.1 North America: Bronchodilators Sales Forecast (2021-2026)
12.2.2 North America: Bronchodilators Revenue Forecast (2021-2026)
12.2.3 North America: Bronchodilators Market Size Forecast by Country (2021-2026)
12.3 Europe Bronchodilators Market Size Forecast (2021-2026)
12.3.1 Europe: Bronchodilators Sales Forecast (2021-2026)
12.3.2 Europe: Bronchodilators Revenue Forecast (2021-2026)
12.3.3 Europe: Bronchodilators Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bronchodilators Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bronchodilators Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bronchodilators Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bronchodilators Market Size Forecast by Region (2021-2026)
12.5 Latin America Bronchodilators Market Size Forecast (2021-2026)
12.5.1 Latin America: Bronchodilators Sales Forecast (2021-2026)
12.5.2 Latin America: Bronchodilators Revenue Forecast (2021-2026)
12.5.3 Latin America: Bronchodilators Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bronchodilators Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bronchodilators Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bronchodilators Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bronchodilators Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bronchodilators Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bronchodilators Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Bronchodilators Market Segments
Table 2. Ranking of Global Top Bronchodilators Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bronchodilators Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Anticholinergic Bronchodilators
Table 5. Major Manufacturers of Adrenergic Bronchodilators
Table 6. Major Manufacturers of Bronchodilator Combinations
Table 7. Major Manufacturers of Methylxanthines
Table 8. Global Bronchodilators Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Bronchodilators Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Bronchodilators Sales by Regions 2015-2020 (K MT)
Table 11. Global Bronchodilators Sales Market Share by Regions (2015-2020)
Table 12. Global Bronchodilators Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Bronchodilators Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Bronchodilators Sales Share by Manufacturers (2015-2020)
Table 15. Global Bronchodilators Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Bronchodilators by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchodilators as of 2019)
Table 17. Bronchodilators Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Bronchodilators Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Bronchodilators Price (2015-2020) (USD/MT)
Table 20. Bronchodilators Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Bronchodilators Product Type
Table 22. Date of International Manufacturers Enter into Bronchodilators Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Bronchodilators Sales by Type (2015-2020) (K MT)
Table 25. Global Bronchodilators Sales Share by Type (2015-2020)
Table 26. Global Bronchodilators Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Bronchodilators Revenue Share by Type (2015-2020)
Table 28. Bronchodilators Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Bronchodilators Sales by Application (2015-2020) (K MT)
Table 30. Global Bronchodilators Sales Share by Application (2015-2020)
Table 31. North America Bronchodilators Sales by Country (2015-2020) (K MT)
Table 32. North America Bronchodilators Sales Market Share by Country (2015-2020)
Table 33. North America Bronchodilators Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Bronchodilators Revenue Market Share by Country (2015-2020)
Table 35. North America Bronchodilators Sales by Type (2015-2020) (K MT)
Table 36. North America Bronchodilators Sales Market Share by Type (2015-2020)
Table 37. North America Bronchodilators Sales by Application (2015-2020) (K MT)
Table 38. North America Bronchodilators Sales Market Share by Application (2015-2020)
Table 39. Europe Bronchodilators Sales by Country (2015-2020) (K MT)
Table 40. Europe Bronchodilators Sales Market Share by Country (2015-2020)
Table 41. Europe Bronchodilators Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Bronchodilators Revenue Market Share by Country (2015-2020)
Table 43. Europe Bronchodilators Sales by Type (2015-2020) (K MT)
Table 44. Europe Bronchodilators Sales Market Share by Type (2015-2020)
Table 45. Europe Bronchodilators Sales by Application (2015-2020) (K MT)
Table 46. Europe Bronchodilators Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Bronchodilators Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Bronchodilators Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Bronchodilators Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Bronchodilators Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Bronchodilators Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Bronchodilators Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Bronchodilators Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Bronchodilators Sales Market Share by Application (2015-2020)
Table 55. Latin America Bronchodilators Sales by Country (2015-2020) (K MT)
Table 56. Latin America Bronchodilators Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Bronchodilators Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Bronchodilators Revenue Market Share by Country (2015-2020)
Table 59. Latin America Bronchodilators Sales by Type (2015-2020) (K MT)
Table 60. Latin America Bronchodilators Sales Market Share by Type (2015-2020)
Table 61. Latin America Bronchodilators Sales by Application (2015-2020) (K MT)
Table 62. Latin America Bronchodilators Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Bronchodilators Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Bronchodilators Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Bronchodilators Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Bronchodilators Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Bronchodilators Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Bronchodilators Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Bronchodilators Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Bronchodilators Sales Market Share by Application (2015-2020)
Table 71. AstraZeneca Corporation Information
Table 72. AstraZeneca Description and Major Businesses
Table 73. AstraZeneca Bronchodilators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. AstraZeneca Product
Table 75. AstraZeneca Recent Development
Table 76. Boehringer Ingelheim Corporation Information
Table 77. Boehringer Ingelheim Description and Major Businesses
Table 78. Boehringer Ingelheim Bronchodilators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Boehringer Ingelheim Product
Table 80. Boehringer Ingelheim Recent Development
Table 81. GlaxoSmithKline Corporation Information
Table 82. GlaxoSmithKline Description and Major Businesses
Table 83. GlaxoSmithKline Bronchodilators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. GlaxoSmithKline Product
Table 85. GlaxoSmithKline Recent Development
Table 86. F. Hoffmann-La Roche Corporation Information
Table 87. F. Hoffmann-La Roche Description and Major Businesses
Table 88. F. Hoffmann-La Roche Bronchodilators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. F. Hoffmann-La Roche Product
Table 90. F. Hoffmann-La Roche Recent Development
Table 91. Global Bronchodilators Sales Forecast by Regions (2021-2026) (K MT)
Table 92. Global Bronchodilators Sales Market Share Forecast by Regions (2021-2026)
Table 93. Global Bronchodilators Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 94. Global Bronchodilators Revenue Market Share Forecast by Regions (2021-2026)
Table 95. North America: Bronchodilators Sales Forecast by Country (2021-2026) (K MT)
Table 96. North America: Bronchodilators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Europe: Bronchodilators Sales Forecast by Country (2021-2026) (K MT)
Table 98. Europe: Bronchodilators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Asia Pacific: Bronchodilators Sales Forecast by Region (2021-2026) (K MT)
Table 100. Asia Pacific: Bronchodilators Revenue Forecast by Region (2021-2026) (US$ Million)
Table 101. Latin America: Bronchodilators Sales Forecast by Country (2021-2026) (K MT)
Table 102. Latin America: Bronchodilators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Middle East and Africa: Bronchodilators Sales Forecast by Country (2021-2026) (K MT)
Table 104. Middle East and Africa: Bronchodilators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 106. Key Challenges
Table 107. Market Risks
Table 108. Main Points Interviewed from Key Bronchodilators Players
Table 109. Bronchodilators Customers List
Table 110. Bronchodilators Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Bronchodilators Product Picture
Figure 2. Global Bronchodilators Sales Market Share by Type in 2020 & 2026
Figure 3. Anticholinergic Bronchodilators Product Picture
Figure 4. Adrenergic Bronchodilators Product Picture
Figure 5. Bronchodilator Combinations Product Picture
Figure 6. Methylxanthines Product Picture
Figure 7. Global Bronchodilators Sales Market Share by Application in 2020 & 2026
Figure 8. Asthma
Figure 9. COPD
Figure 10. Others
Figure 11. Bronchodilators Report Years Considered
Figure 12. Global Bronchodilators Market Size 2015-2026 (US$ Million)
Figure 13. Global Bronchodilators Sales 2015-2026 (K MT)
Figure 14. Global Bronchodilators Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Bronchodilators Sales Market Share by Region (2015-2020)
Figure 16. Global Bronchodilators Sales Market Share by Region in 2019
Figure 17. Global Bronchodilators Revenue Market Share by Region (2015-2020)
Figure 18. Global Bronchodilators Revenue Market Share by Region in 2019
Figure 19. Global Bronchodilators Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Bronchodilators Revenue in 2019
Figure 21. Bronchodilators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Bronchodilators Sales Market Share by Type (2015-2020)
Figure 23. Global Bronchodilators Sales Market Share by Type in 2019
Figure 24. Global Bronchodilators Revenue Market Share by Type (2015-2020)
Figure 25. Global Bronchodilators Revenue Market Share by Type in 2019
Figure 26. Global Bronchodilators Market Share by Price Range (2015-2020)
Figure 27. Global Bronchodilators Sales Market Share by Application (2015-2020)
Figure 28. Global Bronchodilators Sales Market Share by Application in 2019
Figure 29. Global Bronchodilators Revenue Market Share by Application (2015-2020)
Figure 30. Global Bronchodilators Revenue Market Share by Application in 2019
Figure 31. North America Bronchodilators Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Bronchodilators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Bronchodilators Sales Market Share by Country in 2019
Figure 34. North America Bronchodilators Revenue Market Share by Country in 2019
Figure 35. U.S. Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Bronchodilators Market Share by Type in 2019
Figure 40. North America Bronchodilators Market Share by Application in 2019
Figure 41. Europe Bronchodilators Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Bronchodilators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Bronchodilators Sales Market Share by Country in 2019
Figure 44. Europe Bronchodilators Revenue Market Share by Country in 2019
Figure 45. Germany Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Bronchodilators Market Share by Type in 2019
Figure 56. Europe Bronchodilators Market Share by Application in 2019
Figure 57. Asia Pacific Bronchodilators Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Bronchodilators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Bronchodilators Sales Market Share by Region in 2019
Figure 60. Asia Pacific Bronchodilators Revenue Market Share by Region in 2019
Figure 61. China Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Bronchodilators Market Share by Type in 2019
Figure 84. Asia Pacific Bronchodilators Market Share by Application in 2019
Figure 85. Latin America Bronchodilators Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Bronchodilators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Bronchodilators Sales Market Share by Country in 2019
Figure 88. Latin America Bronchodilators Revenue Market Share by Country in 2019
Figure 89. Mexico Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Bronchodilators Market Share by Type in 2019
Figure 96. Latin America Bronchodilators Market Share by Application in 2019
Figure 97. Middle East and Africa Bronchodilators Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Bronchodilators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Bronchodilators Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Bronchodilators Revenue Market Share by Country in 2019
Figure 101. Turkey Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Bronchodilators Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Bronchodilators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Bronchodilators Market Share by Type in 2019
Figure 108. Middle East and Africa Bronchodilators Market Share by Application in 2019
Figure 109. North America Bronchodilators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Bronchodilators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Bronchodilators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Bronchodilators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Bronchodilators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Bronchodilators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Bronchodilators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Bronchodilators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Bronchodilators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Bronchodilators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
COPD薬剤の世界市場（～2026年） COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors， steroids, combination therapies, etc. One of the emerging trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to tre…- 喘息・COPDの世界市場（～2026年） Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway. Asthma is usually considered a sepa…
- 喘息管理製品の世界市場（～2026年） Asthma is a chronic disease, which cannot be cured only appropriate management is possible to control the disease. Asthma targets airways of the lungs causing it to inflame, swallow and tightens the airway of the lungs, causing respiratory tract infection and causing symptoms such as coughing, short…
- 吸入・点鼻薬ジェネリック医薬品の世界市場（～2026年） Inhalation and Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by hay fever or other allergies. Quality control could pose an issue in the overall growth of generic inhalers and nasal spray sales, an issue that governments are trying…
- 慢性閉塞性肺疾患（COPD）の世界市場（～2026年） Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…